The use of N-aryl amide derivatives
as spatially acting insecticides
remains relatively unexplored. To expand this knowledge, we synthesized
eighty-nine N-aryl amide analogues and screened them for mortality
against an insecticide-susceptible strain of Aedes
aegypti mosquitoes, Orlando (OR), using a vapor exposure
glass tube assay. Of the screened compounds, twenty-two produced >92%
mortality at 24 h and warranted further investigation to determine
LC50 values. Fifteen of these analogues had LC50 values within 2 orders of magnitude of transfluthrin, and of significant
interest, N-(2,6-dichloro-4-(trifluoromethyl)phenyl)-2,2,3,3,3-pentafluoropropanamide
(compound 70) was nearly as potent as transfluthrin and
exhibited greater toxicity than metofluthrin when screened against
OR A. aegypti. Compounds exhibiting
potent toxicity against OR A. aegypti or whose structure–activity relationship potentially offered
beneficial insights into structure optimization were screened against
the insecticide-resistant, Puerto Rico (PR), strain of A. Aegypti, and it was discovered that not only did
these N-arylamides typically show little resistance, some such as N-(2,6-dichloropyridin-4-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
(compound 36) and 2,2,3,3,4,4,4-heptafluoro-N-(3,4,5-trifluorophenyl)butanamide (compound 40) were
actually more potent against the PR mosquitoes. Due to this promising
insecticidal activity, five compounds were administered orally to
mice to determine acute oral rodent toxicity. All five compounds were
found to have mouse oral toxicity LD50 values well above
the minimum safe level as set by the Innovative Vector Control Consortium
(50 mg/kg). In addition to the promising biological activity documented
here, we report the structure–activity relationship analysis
used to guide the derivatization approach taken and to further inform
future efforts in the development of N-arylamides as potential resistance-breaking,
spatially acting insecticides.